Literature DB >> 23995422

Globular glial tauopathies (GGT): consensus recommendations.

Zeshan Ahmed1, Gabor G Kovacs2, Eileen H Bigio3, Herbert Budka2, Dennis W Dickson4, Isidro Ferrer5, Bernardino Ghetti6, Giorgio Giaccone7, Kimmo J Hatanpaa8, Janice L Holton1, Keith A Josephs9, James Powers10, Salvatore Spina6, Hitoshi Takahashi11, Charles L White8, Tamas Revesz1.   

Abstract

Recent studies have highlighted a group of 4-repeat (4R) tauopathies that are characterised neuropathologically by widespread, globular glial inclusions (GGIs). Tau immunohistochemistry reveals 4R immunoreactive globular oligodendroglial and astrocytic inclusions and the latter are predominantly negative for Gallyas silver staining. These cases are associated with a range of clinical presentations, which correlate with the severity and distribution of underlying tau pathology and neurodegeneration. Their heterogeneous clinicopathological features combined with their rarity and under-recognition have led to cases characterised by GGIs being described in the literature using various and redundant terminologies. In this report, a group of neuropathologists form a consensus on the terminology and classification of cases with GGIs. After studying microscopic images from previously reported cases with suspected GGIs (n = 22), this panel of neuropathologists with extensive experience in the diagnosis of neurodegenerative diseases and a documented record of previous experience with at least one case with GGIs, agreed that (1) GGIs were present in all the cases reviewed; (2) the morphology of globular astrocytic inclusions was different to tufted astrocytes and finally that (3) the cases represented a number of different neuropathological subtypes. They also agreed that the different morphological subtypes are likely to be part of a spectrum of a distinct disease entity, for which they recommend that the overarching term globular glial tauopathy (GGT) should be used. Type I cases typically present with frontotemporal dementia, which correlates with the fronto-temporal distribution of pathology. Type II cases are characterised by pyramidal features reflecting motor cortex involvement and corticospinal tract degeneration. Type III cases can present with a combination of frontotemporal dementia and motor neuron disease with fronto-temporal cortex, motor cortex and corticospinal tract being severely affected. Extrapyramidal features can be present in Type II and III cases and significant degeneration of the white matter is a feature of all GGT subtypes. Improved detection and classification will be necessary for the establishment of neuropathological and clinical diagnostic research criteria in the future.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23995422      PMCID: PMC3914659          DOI: 10.1007/s00401-013-1171-0

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  24 in total

1.  Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease.

Authors:  N J Cairns; P F Atkinson; D P Hanger; B H Anderton; S E Daniel; P L Lantos
Journal:  Neurosci Lett       Date:  1997-07-11       Impact factor: 3.046

2.  Primary progressive aphasia with glial cytoplasmic inclusions.

Authors:  J A Molina; A Probst; C Villanueva; F J Jiménez-Jiménez; S Madero; N Torres; F Bermejo
Journal:  Eur Neurol       Date:  1998-08       Impact factor: 1.710

3.  Frontal lobe dementia with novel tauopathy: sporadic multiple system tauopathy with dementia.

Authors:  E H Bigio; A M Lipton; S H Yen; M L Hutton; M Baker; P Nacharaju; C L White; P Davies; W Lin; D W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2001-04       Impact factor: 3.685

4.  Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments.

Authors:  M G Spillantini; M Goedert; R A Crowther; J R Murrell; M R Farlow; B Ghetti
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Silver staining of Alzheimer's neurofibrillary changes by means of physical development.

Authors:  F Gallyas
Journal:  Acta Morphol Acad Sci Hung       Date:  1971

6.  Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation.

Authors:  Shintaro Hayashi; Yasuko Toyoshima; Masato Hasegawa; Yuri Umeda; Koichi Wakabayashi; Susumu Tokiguchi; Takeshi Iwatsubo; Hitoshi Takahashi
Journal:  Ann Neurol       Date:  2002-04       Impact factor: 10.422

7.  A novel leukoencephalopathy associated with tau deposits primarily in white matter glia.

Authors:  J M Powers; N P Byrne; M Ito; M Takao; D Yankopoulou; M G Spillantini; B Ghetti
Journal:  Acta Neuropathol       Date:  2003-05-29       Impact factor: 17.088

8.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.

Authors:  M G Spillantini; J R Murrell; M Goedert; M R Farlow; A Klug; B Ghetti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

9.  Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.

Authors:  I Ferrer; I Hernández; M Boada; A Llorente; M J Rey; A Cardozo; M Ezquerra; B Puig
Journal:  Acta Neuropathol       Date:  2003-08-29       Impact factor: 17.088

10.  Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies.

Authors:  Zeshan Ahmed; Karen M Doherty; Laura Silveira-Moriyama; Rina Bandopadhyay; Tammaryn Lashley; Adamantios Mamais; Geshanthi Hondhamuni; Selina Wray; Jia Newcombe; Sean S O'Sullivan; Stephen Wroe; Rohan de Silva; Janice L Holton; Andrew J Lees; Tamas Revesz
Journal:  Acta Neuropathol       Date:  2011-07-21       Impact factor: 17.088

View more
  66 in total

1.  A novel tau mutation, p.K317N, causes globular glial tauopathy.

Authors:  Pawel Tacik; Michael DeTure; Wen-Lang Lin; Monica Sanchez Contreras; Aleksandra Wojtas; Kelly M Hinkle; Shinsuke Fujioka; Matthew C Baker; Ronald L Walton; Yari Carlomagno; Patricia H Brown; Audrey J Strongosky; Naomi Kouri; Melissa E Murray; Leonard Petrucelli; Keith A Josephs; Rosa Rademakers; Owen A Ross; Zbigniew K Wszolek; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2015-04-22       Impact factor: 17.088

Review 2.  FTD and ALS--translating mouse studies into clinical trials.

Authors:  Lars M Ittner; Glenda M Halliday; Jillian J Kril; Jürgen Götz; John R Hodges; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2015-05-05       Impact factor: 42.937

3.  Tauopathy with hippocampal 4-repeat tau immunoreactive spherical inclusions: a report of three cases.

Authors:  Gabor G Kovacs; Linda K Kwong; Murray Grossman; David J Irwin; Edward B Lee; John L Robinson; Eunran Suh; Vivianna M Van Deerlin; Virginia M Lee; John Q Trojanowski
Journal:  Brain Pathol       Date:  2017-01-19       Impact factor: 6.508

4.  Globular glial tauopathy with a mutation in MAPT and unusual TDP-43 proteinopathy in a patient with behavioural-variant frontotemporal dementia.

Authors:  Shelley L Forrest; Claire E Shepherd; Heather McCann; John B Kwok; Glenda M Halliday; Jillian J Kril
Journal:  Acta Neuropathol       Date:  2021-03-20       Impact factor: 17.088

Review 5.  Tauopathies as clinicopathological entities.

Authors:  David J Irwin
Journal:  Parkinsonism Relat Disord       Date:  2015-09-08       Impact factor: 4.891

Review 6.  RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.

Authors:  Jeffrey W Hofmann; William W Seeley; Eric J Huang
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

7.  Atypical Alzheimer's disease in an elderly United States resident with amyotrophic lateral sclerosis and pathological tau in spinal motor neurons.

Authors:  Leo F McCluskey; Felix Geser; Lauren B Elman; Vivianna M Van Deerlin; John L Robinson; Virginia M-Y Lee; John Q Trojanowski
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-05-09       Impact factor: 4.092

8.  Progressive supranuclear palsy and primary lateral sclerosis secondary to globular glial tauopathy: a case report and a practical theoretical framework for the clinical prediction of this rare pathological entity.

Authors:  Andy J Liu; Jessica E Chang; Georges Naasan; Adam L Boxer; Bruce L Miller; Salvatore Spina
Journal:  Neurocase       Date:  2020-02-23       Impact factor: 0.881

9.  Globular Glial Tauopathy Presenting as Semantic Variant Primary Progressive Aphasia.

Authors:  Jonathan Graff-Radford; Keith A Josephs; Joseph E Parisi; Dennis W Dickson; Caterina Giannini; Bradley F Boeve
Journal:  JAMA Neurol       Date:  2016-01       Impact factor: 18.302

Review 10.  Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.

Authors:  Gabor G Kovacs; Isidro Ferrer; Lea T Grinberg; Irina Alafuzoff; Johannes Attems; Herbert Budka; Nigel J Cairns; John F Crary; Charles Duyckaerts; Bernardino Ghetti; Glenda M Halliday; James W Ironside; Seth Love; Ian R Mackenzie; David G Munoz; Melissa E Murray; Peter T Nelson; Hitoshi Takahashi; John Q Trojanowski; Olaf Ansorge; Thomas Arzberger; Atik Baborie; Thomas G Beach; Kevin F Bieniek; Eileen H Bigio; Istvan Bodi; Brittany N Dugger; Mel Feany; Ellen Gelpi; Stephen M Gentleman; Giorgio Giaccone; Kimmo J Hatanpaa; Richard Heale; Patrick R Hof; Monika Hofer; Tibor Hortobágyi; Kurt Jellinger; Gregory A Jicha; Paul Ince; Julia Kofler; Enikö Kövari; Jillian J Kril; David M Mann; Radoslav Matej; Ann C McKee; Catriona McLean; Ivan Milenkovic; Thomas J Montine; Shigeo Murayama; Edward B Lee; Jasmin Rahimi; Roberta D Rodriguez; Annemieke Rozemüller; Julie A Schneider; Christian Schultz; William Seeley; Danielle Seilhean; Colin Smith; Fabrizio Tagliavini; Masaki Takao; Dietmar Rudolf Thal; Jon B Toledo; Markus Tolnay; Juan C Troncoso; Harry V Vinters; Serge Weis; Stephen B Wharton; Charles L White; Thomas Wisniewski; John M Woulfe; Masahito Yamada; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2015-12-10       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.